1,000 Patient ALAMO Study will Evaluate the Clinical Utility of LungCare to Detect Transplant Infection and RejectionSOUTH SAN FRANCISCO, Calif.,…
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 16, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives…
atai Impact’s first major initiative will support promising academics in researching the therapeutic potential of psychedelic compounds to address unmet…
CAMBRIDGE, Mass., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of…
- In vivo data presented at ASH Annual Meeting demonstrated strong antitumor activity against human lymphoma cell lines with CNTY-101…
CLN-081 continues to demonstrate a differentiated clinical profile at the recommended Phase 2 dose of 100mg BID Continued high response…
– DSMB evaluated both safety and efficacy data in recommending cohort progression – – Data from third patient cohort confirm…
GATINEAU, Quebec, Dec. 16, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) today announced…
2022 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Silent period11 January 2022Annual report 20218…
Correction – Admission Date for New Ordinary Shares Included This announcement contains inside information for the purposes of Article 7…